nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefadroxil—Haemorrhage—Melphalan—ovarian cancer	0.0046	0.0046	CcSEcCtD
Cefadroxil—Phosphatase alkaline increased—Docetaxel—ovarian cancer	0.00456	0.00456	CcSEcCtD
Cefadroxil—Blood alkaline phosphatase increased—Paclitaxel—ovarian cancer	0.00449	0.00449	CcSEcCtD
Cefadroxil—Swelling—Paclitaxel—ovarian cancer	0.00443	0.00443	CcSEcCtD
Cefadroxil—Angioedema—Chlorambucil—ovarian cancer	0.0042	0.0042	CcSEcCtD
Cefadroxil—Agranulocytosis—Vinorelbine—ovarian cancer	0.00418	0.00418	CcSEcCtD
Cefadroxil—Convulsion—Chlorambucil—ovarian cancer	0.00398	0.00398	CcSEcCtD
Cefadroxil—Muscle spasms—Topotecan—ovarian cancer	0.00393	0.00393	CcSEcCtD
Cefadroxil—Blood alkaline phosphatase increased—Docetaxel—ovarian cancer	0.00381	0.00381	CcSEcCtD
Cefadroxil—Swelling—Docetaxel—ovarian cancer	0.00375	0.00375	CcSEcCtD
Cefadroxil—Angioedema—Topotecan—ovarian cancer	0.00374	0.00374	CcSEcCtD
Cefadroxil—Hepatic failure—Docetaxel—ovarian cancer	0.00368	0.00368	CcSEcCtD
Cefadroxil—Thrombocytopenia—Chlorambucil—ovarian cancer	0.00367	0.00367	CcSEcCtD
Cefadroxil—Blood creatinine increased—Paclitaxel—ovarian cancer	0.00366	0.00366	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Paclitaxel—ovarian cancer	0.00352	0.00352	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Paclitaxel—ovarian cancer	0.00352	0.00352	CcSEcCtD
Cefadroxil—Cramp muscle—Paclitaxel—ovarian cancer	0.00352	0.00352	CcSEcCtD
Cefadroxil—Arthralgia—Topotecan—ovarian cancer	0.00348	0.00348	CcSEcCtD
Cefadroxil—Convulsion—Melphalan—ovarian cancer	0.00347	0.00347	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Paclitaxel—ovarian cancer	0.00344	0.00344	CcSEcCtD
Cefadroxil—Anaphylactic shock—Topotecan—ovarian cancer	0.00334	0.00334	CcSEcCtD
Cefadroxil—Dyspepsia—Chlorambucil—ovarian cancer	0.0033	0.0033	CcSEcCtD
Cefadroxil—Anaphylactic shock—Melphalan—ovarian cancer	0.00327	0.00327	CcSEcCtD
Cefadroxil—Thrombocytopenia—Topotecan—ovarian cancer	0.00327	0.00327	CcSEcCtD
Cefadroxil—Blood bilirubin increased—Epirubicin—ovarian cancer	0.00325	0.00325	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.00324	0.00324	CcSEcCtD
Cefadroxil—Creatinine increased—Epirubicin—ovarian cancer	0.00323	0.00323	CcSEcCtD
Cefadroxil—Pancytopenia—Paclitaxel—ovarian cancer	0.00321	0.00321	CcSEcCtD
Cefadroxil—Thrombocytopenia—Melphalan—ovarian cancer	0.0032	0.0032	CcSEcCtD
Cefadroxil—Angioedema—Vinorelbine—ovarian cancer	0.0032	0.0032	CcSEcCtD
Cefadroxil—Neutropenia—Paclitaxel—ovarian cancer	0.00316	0.00316	CcSEcCtD
Cefadroxil—Vertigo—Vinorelbine—ovarian cancer	0.00314	0.00314	CcSEcCtD
Cefadroxil—Phosphatase alkaline increased—Epirubicin—ovarian cancer	0.00308	0.00308	CcSEcCtD
Cefadroxil—Vaginal inflammation—Epirubicin—ovarian cancer	0.00308	0.00308	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00306	0.00306	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00304	0.00304	CcSEcCtD
Cefadroxil—Blood bilirubin increased—Doxorubicin—ovarian cancer	0.00301	0.00301	CcSEcCtD
Cefadroxil—Creatinine increased—Doxorubicin—ovarian cancer	0.00299	0.00299	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Paclitaxel—ovarian cancer	0.00298	0.00298	CcSEcCtD
Cefadroxil—Cramp muscle—Docetaxel—ovarian cancer	0.00298	0.00298	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Docetaxel—ovarian cancer	0.00298	0.00298	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Docetaxel—ovarian cancer	0.00298	0.00298	CcSEcCtD
Cefadroxil—Urticaria—Chlorambucil—ovarian cancer	0.00298	0.00298	CcSEcCtD
Cefadroxil—Arthralgia—Vinorelbine—ovarian cancer	0.00298	0.00298	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00298	0.00298	CcSEcCtD
Cefadroxil—Body temperature increased—Chlorambucil—ovarian cancer	0.00296	0.00296	CcSEcCtD
Cefadroxil—Abdominal pain—Chlorambucil—ovarian cancer	0.00296	0.00296	CcSEcCtD
Cefadroxil—Dyspepsia—Topotecan—ovarian cancer	0.00294	0.00294	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Docetaxel—ovarian cancer	0.00292	0.00292	CcSEcCtD
Cefadroxil—Vaginal infection—Epirubicin—ovarian cancer	0.0029	0.0029	CcSEcCtD
Cefadroxil—Blood urea increased—Epirubicin—ovarian cancer	0.0029	0.0029	CcSEcCtD
Cefadroxil—Aplastic anaemia—Epirubicin—ovarian cancer	0.00289	0.00289	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00288	0.00288	CcSEcCtD
Cefadroxil—Dyspepsia—Melphalan—ovarian cancer	0.00288	0.00288	CcSEcCtD
Cefadroxil—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00285	0.00285	CcSEcCtD
Cefadroxil—Phosphatase alkaline increased—Doxorubicin—ovarian cancer	0.00285	0.00285	CcSEcCtD
Cefadroxil—Vaginal inflammation—Doxorubicin—ovarian cancer	0.00285	0.00285	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00282	0.00282	CcSEcCtD
Cefadroxil—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00279	0.00279	CcSEcCtD
Cefadroxil—Hypersensitivity—Chlorambucil—ovarian cancer	0.00276	0.00276	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Topotecan—ovarian cancer	0.00273	0.00273	CcSEcCtD
Cefadroxil—Pancytopenia—Docetaxel—ovarian cancer	0.00272	0.00272	CcSEcCtD
Cefadroxil—Haemoglobin—Paclitaxel—ovarian cancer	0.00272	0.00272	CcSEcCtD
Cefadroxil—Haemorrhage—Paclitaxel—ovarian cancer	0.0027	0.0027	CcSEcCtD
Cefadroxil—Asthenia—Chlorambucil—ovarian cancer	0.00269	0.00269	CcSEcCtD
Cefadroxil—Vaginal infection—Doxorubicin—ovarian cancer	0.00269	0.00269	CcSEcCtD
Cefadroxil—Blood urea increased—Doxorubicin—ovarian cancer	0.00269	0.00269	CcSEcCtD
Cefadroxil—Neutropenia—Docetaxel—ovarian cancer	0.00268	0.00268	CcSEcCtD
Cefadroxil—Aplastic anaemia—Doxorubicin—ovarian cancer	0.00267	0.00267	CcSEcCtD
Cefadroxil—Pruritus—Chlorambucil—ovarian cancer	0.00265	0.00265	CcSEcCtD
Cefadroxil—Urticaria—Topotecan—ovarian cancer	0.00265	0.00265	CcSEcCtD
Cefadroxil—Abdominal pain—Topotecan—ovarian cancer	0.00264	0.00264	CcSEcCtD
Cefadroxil—Body temperature increased—Topotecan—ovarian cancer	0.00264	0.00264	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.0026	0.0026	CcSEcCtD
Cefadroxil—Urticaria—Melphalan—ovarian cancer	0.0026	0.0026	CcSEcCtD
Cefadroxil—Blood alkaline phosphatase increased—Epirubicin—ovarian cancer	0.00257	0.00257	CcSEcCtD
Cefadroxil—Diarrhoea—Chlorambucil—ovarian cancer	0.00256	0.00256	CcSEcCtD
Cefadroxil—Hepatic function abnormal—Epirubicin—ovarian cancer	0.00255	0.00255	CcSEcCtD
Cefadroxil—Erythema multiforme—Paclitaxel—ovarian cancer	0.00255	0.00255	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.00253	0.00253	CcSEcCtD
Cefadroxil—Hepatic failure—Epirubicin—ovarian cancer	0.00248	0.00248	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00246	0.00246	CcSEcCtD
Cefadroxil—Hypersensitivity—Topotecan—ovarian cancer	0.00246	0.00246	CcSEcCtD
Cefadroxil—Hypersensitivity—Melphalan—ovarian cancer	0.00241	0.00241	CcSEcCtD
Cefadroxil—Asthenia—Topotecan—ovarian cancer	0.00239	0.00239	CcSEcCtD
Cefadroxil—Vomiting—Chlorambucil—ovarian cancer	0.00238	0.00238	CcSEcCtD
Cefadroxil—Agranulocytosis—Docetaxel—ovarian cancer	0.00238	0.00238	CcSEcCtD
Cefadroxil—Blood alkaline phosphatase increased—Doxorubicin—ovarian cancer	0.00238	0.00238	CcSEcCtD
Cefadroxil—Hepatic function abnormal—Doxorubicin—ovarian cancer	0.00236	0.00236	CcSEcCtD
Cefadroxil—Pruritus—Topotecan—ovarian cancer	0.00236	0.00236	CcSEcCtD
Cefadroxil—Asthenia—Melphalan—ovarian cancer	0.00234	0.00234	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00233	0.00233	CcSEcCtD
Cefadroxil—Pruritus—Melphalan—ovarian cancer	0.00231	0.00231	CcSEcCtD
Cefadroxil—Tension—Paclitaxel—ovarian cancer	0.00231	0.00231	CcSEcCtD
Cefadroxil—Haemoglobin—Docetaxel—ovarian cancer	0.0023	0.0023	CcSEcCtD
Cefadroxil—Hepatic failure—Doxorubicin—ovarian cancer	0.0023	0.0023	CcSEcCtD
Cefadroxil—Haemorrhage—Docetaxel—ovarian cancer	0.00229	0.00229	CcSEcCtD
Cefadroxil—Nervousness—Paclitaxel—ovarian cancer	0.00228	0.00228	CcSEcCtD
Cefadroxil—Diarrhoea—Topotecan—ovarian cancer	0.00228	0.00228	CcSEcCtD
Cefadroxil—Urticaria—Vinorelbine—ovarian cancer	0.00227	0.00227	CcSEcCtD
Cefadroxil—Muscle spasms—Paclitaxel—ovarian cancer	0.00226	0.00226	CcSEcCtD
Cefadroxil—Abdominal pain—Vinorelbine—ovarian cancer	0.00226	0.00226	CcSEcCtD
Cefadroxil—Body temperature increased—Vinorelbine—ovarian cancer	0.00226	0.00226	CcSEcCtD
Cefadroxil—Diarrhoea—Melphalan—ovarian cancer	0.00224	0.00224	CcSEcCtD
Cefadroxil—Nausea—Chlorambucil—ovarian cancer	0.00223	0.00223	CcSEcCtD
Cefadroxil—Dizziness—Topotecan—ovarian cancer	0.00221	0.00221	CcSEcCtD
Cefadroxil—Erythema multiforme—Docetaxel—ovarian cancer	0.00217	0.00217	CcSEcCtD
Cefadroxil—Angioedema—Paclitaxel—ovarian cancer	0.00215	0.00215	CcSEcCtD
Cefadroxil—Vomiting—Topotecan—ovarian cancer	0.00212	0.00212	CcSEcCtD
Cefadroxil—Vertigo—Paclitaxel—ovarian cancer	0.00211	0.00211	CcSEcCtD
Cefadroxil—Rash—Topotecan—ovarian cancer	0.0021	0.0021	CcSEcCtD
Cefadroxil—Hypersensitivity—Vinorelbine—ovarian cancer	0.0021	0.0021	CcSEcCtD
Cefadroxil—Dermatitis—Topotecan—ovarian cancer	0.0021	0.0021	CcSEcCtD
Cefadroxil—Blood creatinine increased—Epirubicin—ovarian cancer	0.00209	0.00209	CcSEcCtD
Cefadroxil—Headache—Topotecan—ovarian cancer	0.00209	0.00209	CcSEcCtD
Cefadroxil—Vomiting—Melphalan—ovarian cancer	0.00208	0.00208	CcSEcCtD
Cefadroxil—Rash—Melphalan—ovarian cancer	0.00206	0.00206	CcSEcCtD
Cefadroxil—Dermatitis—Melphalan—ovarian cancer	0.00206	0.00206	CcSEcCtD
Cefadroxil—Asthenia—Vinorelbine—ovarian cancer	0.00205	0.00205	CcSEcCtD
Cefadroxil—Convulsion—Paclitaxel—ovarian cancer	0.00204	0.00204	CcSEcCtD
Cefadroxil—Pruritus—Vinorelbine—ovarian cancer	0.00202	0.00202	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.00201	0.00201	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.00201	0.00201	CcSEcCtD
Cefadroxil—Arthralgia—Paclitaxel—ovarian cancer	0.002	0.002	CcSEcCtD
Cefadroxil—Nausea—Topotecan—ovarian cancer	0.00198	0.00198	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.00197	0.00197	CcSEcCtD
Cefadroxil—Diarrhoea—Vinorelbine—ovarian cancer	0.00195	0.00195	CcSEcCtD
Cefadroxil—Nausea—Melphalan—ovarian cancer	0.00194	0.00194	CcSEcCtD
Cefadroxil—Blood creatinine increased—Doxorubicin—ovarian cancer	0.00194	0.00194	CcSEcCtD
Cefadroxil—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00192	0.00192	CcSEcCtD
Cefadroxil—Muscle spasms—Docetaxel—ovarian cancer	0.00192	0.00192	CcSEcCtD
Cefadroxil—Eosinophilia—Epirubicin—ovarian cancer	0.00191	0.00191	CcSEcCtD
Cefadroxil—Dizziness—Vinorelbine—ovarian cancer	0.00189	0.00189	CcSEcCtD
Cefadroxil—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00188	0.00188	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.00186	0.00186	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.00186	0.00186	CcSEcCtD
Cefadroxil—Pancytopenia—Epirubicin—ovarian cancer	0.00183	0.00183	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.00182	0.00182	CcSEcCtD
Cefadroxil—Vomiting—Vinorelbine—ovarian cancer	0.00181	0.00181	CcSEcCtD
Cefadroxil—Neutropenia—Epirubicin—ovarian cancer	0.0018	0.0018	CcSEcCtD
Cefadroxil—Rash—Vinorelbine—ovarian cancer	0.0018	0.0018	CcSEcCtD
Cefadroxil—Dermatitis—Vinorelbine—ovarian cancer	0.0018	0.0018	CcSEcCtD
Cefadroxil—Headache—Vinorelbine—ovarian cancer	0.00179	0.00179	CcSEcCtD
Cefadroxil—Eosinophilia—Doxorubicin—ovarian cancer	0.00177	0.00177	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00175	0.00175	CcSEcCtD
Cefadroxil—Convulsion—Docetaxel—ovarian cancer	0.00173	0.00173	CcSEcCtD
Cefadroxil—Drowsiness—Epirubicin—ovarian cancer	0.00172	0.00172	CcSEcCtD
Cefadroxil—Somnolence—Paclitaxel—ovarian cancer	0.00171	0.00171	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.00171	0.00171	CcSEcCtD
Cefadroxil—Arthralgia—Docetaxel—ovarian cancer	0.0017	0.0017	CcSEcCtD
Cefadroxil—Pancytopenia—Doxorubicin—ovarian cancer	0.0017	0.0017	CcSEcCtD
Cefadroxil—Nausea—Vinorelbine—ovarian cancer	0.0017	0.0017	CcSEcCtD
Cefadroxil—Dyspepsia—Paclitaxel—ovarian cancer	0.00169	0.00169	CcSEcCtD
Cefadroxil—Neutropenia—Doxorubicin—ovarian cancer	0.00167	0.00167	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00166	0.00166	CcSEcCtD
Cefadroxil—Anaphylactic shock—Docetaxel—ovarian cancer	0.00163	0.00163	CcSEcCtD
Cefadroxil—Agranulocytosis—Epirubicin—ovarian cancer	0.00161	0.00161	CcSEcCtD
Cefadroxil—Thrombocytopenia—Docetaxel—ovarian cancer	0.00159	0.00159	CcSEcCtD
Cefadroxil—Drowsiness—Doxorubicin—ovarian cancer	0.00159	0.00159	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.00158	0.00158	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00157	0.00157	CcSEcCtD
Cefadroxil—Haemoglobin—Epirubicin—ovarian cancer	0.00155	0.00155	CcSEcCtD
Cefadroxil—Haemorrhage—Epirubicin—ovarian cancer	0.00154	0.00154	CcSEcCtD
Cefadroxil—Urticaria—Paclitaxel—ovarian cancer	0.00152	0.00152	CcSEcCtD
Cefadroxil—Abdominal pain—Paclitaxel—ovarian cancer	0.00152	0.00152	CcSEcCtD
Cefadroxil—Body temperature increased—Paclitaxel—ovarian cancer	0.00152	0.00152	CcSEcCtD
Cefadroxil—Agranulocytosis—Doxorubicin—ovarian cancer	0.00149	0.00149	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00148	0.00148	CcSEcCtD
Cefadroxil—Erythema multiforme—Epirubicin—ovarian cancer	0.00146	0.00146	CcSEcCtD
Cefadroxil—Somnolence—Docetaxel—ovarian cancer	0.00145	0.00145	CcSEcCtD
Cefadroxil—Haemoglobin—Doxorubicin—ovarian cancer	0.00144	0.00144	CcSEcCtD
Cefadroxil—Dyspepsia—Docetaxel—ovarian cancer	0.00143	0.00143	CcSEcCtD
Cefadroxil—Haemorrhage—Doxorubicin—ovarian cancer	0.00143	0.00143	CcSEcCtD
Cefadroxil—Hypersensitivity—Paclitaxel—ovarian cancer	0.00141	0.00141	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.0014	0.0014	CcSEcCtD
Cefadroxil—Asthenia—Paclitaxel—ovarian cancer	0.00138	0.00138	CcSEcCtD
Cefadroxil—Pruritus—Paclitaxel—ovarian cancer	0.00136	0.00136	CcSEcCtD
Cefadroxil—Erythema multiforme—Doxorubicin—ovarian cancer	0.00135	0.00135	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00133	0.00133	CcSEcCtD
Cefadroxil—Tension—Epirubicin—ovarian cancer	0.00132	0.00132	CcSEcCtD
Cefadroxil—Diarrhoea—Paclitaxel—ovarian cancer	0.00131	0.00131	CcSEcCtD
Cefadroxil—Nervousness—Epirubicin—ovarian cancer	0.00131	0.00131	CcSEcCtD
Cefadroxil—Muscle spasms—Epirubicin—ovarian cancer	0.00129	0.00129	CcSEcCtD
Cefadroxil—Abdominal pain—Docetaxel—ovarian cancer	0.00129	0.00129	CcSEcCtD
Cefadroxil—Body temperature increased—Docetaxel—ovarian cancer	0.00129	0.00129	CcSEcCtD
Cefadroxil—Dizziness—Paclitaxel—ovarian cancer	0.00127	0.00127	CcSEcCtD
Cefadroxil—Tension—Doxorubicin—ovarian cancer	0.00122	0.00122	CcSEcCtD
Cefadroxil—Vomiting—Paclitaxel—ovarian cancer	0.00122	0.00122	CcSEcCtD
Cefadroxil—Rash—Paclitaxel—ovarian cancer	0.00121	0.00121	CcSEcCtD
Cefadroxil—Dermatitis—Paclitaxel—ovarian cancer	0.00121	0.00121	CcSEcCtD
Cefadroxil—Nervousness—Doxorubicin—ovarian cancer	0.00121	0.00121	CcSEcCtD
Cefadroxil—Vertigo—Epirubicin—ovarian cancer	0.00121	0.00121	CcSEcCtD
Cefadroxil—Headache—Paclitaxel—ovarian cancer	0.0012	0.0012	CcSEcCtD
Cefadroxil—Hypersensitivity—Docetaxel—ovarian cancer	0.0012	0.0012	CcSEcCtD
Cefadroxil—Muscle spasms—Doxorubicin—ovarian cancer	0.0012	0.0012	CcSEcCtD
Cefadroxil—Asthenia—Docetaxel—ovarian cancer	0.00117	0.00117	CcSEcCtD
Cefadroxil—Convulsion—Epirubicin—ovarian cancer	0.00117	0.00117	CcSEcCtD
Cefadroxil—Pruritus—Docetaxel—ovarian cancer	0.00115	0.00115	CcSEcCtD
Cefadroxil—Arthralgia—Epirubicin—ovarian cancer	0.00114	0.00114	CcSEcCtD
Cefadroxil—Nausea—Paclitaxel—ovarian cancer	0.00114	0.00114	CcSEcCtD
Cefadroxil—Vertigo—Doxorubicin—ovarian cancer	0.00112	0.00112	CcSEcCtD
Cefadroxil—Diarrhoea—Docetaxel—ovarian cancer	0.00111	0.00111	CcSEcCtD
Cefadroxil—Anaphylactic shock—Epirubicin—ovarian cancer	0.0011	0.0011	CcSEcCtD
Cefadroxil—Convulsion—Doxorubicin—ovarian cancer	0.00108	0.00108	CcSEcCtD
Cefadroxil—Dizziness—Docetaxel—ovarian cancer	0.00108	0.00108	CcSEcCtD
Cefadroxil—Thrombocytopenia—Epirubicin—ovarian cancer	0.00107	0.00107	CcSEcCtD
Cefadroxil—Arthralgia—Doxorubicin—ovarian cancer	0.00106	0.00106	CcSEcCtD
Cefadroxil—Vomiting—Docetaxel—ovarian cancer	0.00103	0.00103	CcSEcCtD
Cefadroxil—Rash—Docetaxel—ovarian cancer	0.00103	0.00103	CcSEcCtD
Cefadroxil—Dermatitis—Docetaxel—ovarian cancer	0.00102	0.00102	CcSEcCtD
Cefadroxil—Headache—Docetaxel—ovarian cancer	0.00102	0.00102	CcSEcCtD
Cefadroxil—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00102	0.00102	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.001	0.001	CcSEcCtD
Cefadroxil—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000994	0.000994	CcSEcCtD
Cefadroxil—Somnolence—Epirubicin—ovarian cancer	0.000976	0.000976	CcSEcCtD
Cefadroxil—Nausea—Docetaxel—ovarian cancer	0.000966	0.000966	CcSEcCtD
Cefadroxil—Dyspepsia—Epirubicin—ovarian cancer	0.000966	0.000966	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000947	0.000947	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000925	0.000925	CcSEcCtD
Cefadroxil—Somnolence—Doxorubicin—ovarian cancer	0.000903	0.000903	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000897	0.000897	CcSEcCtD
Cefadroxil—Dyspepsia—Doxorubicin—ovarian cancer	0.000894	0.000894	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000877	0.000877	CcSEcCtD
Cefadroxil—Urticaria—Epirubicin—ovarian cancer	0.000872	0.000872	CcSEcCtD
Cefadroxil—Body temperature increased—Epirubicin—ovarian cancer	0.000868	0.000868	CcSEcCtD
Cefadroxil—Abdominal pain—Epirubicin—ovarian cancer	0.000868	0.000868	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.00083	0.00083	CcSEcCtD
Cefadroxil—Hypersensitivity—Epirubicin—ovarian cancer	0.000809	0.000809	CcSEcCtD
Cefadroxil—Urticaria—Doxorubicin—ovarian cancer	0.000807	0.000807	CcSEcCtD
Cefadroxil—Body temperature increased—Doxorubicin—ovarian cancer	0.000803	0.000803	CcSEcCtD
Cefadroxil—Abdominal pain—Doxorubicin—ovarian cancer	0.000803	0.000803	CcSEcCtD
Cefadroxil—Asthenia—Epirubicin—ovarian cancer	0.000787	0.000787	CcSEcCtD
Cefadroxil—Pruritus—Epirubicin—ovarian cancer	0.000776	0.000776	CcSEcCtD
Cefadroxil—Diarrhoea—Epirubicin—ovarian cancer	0.000751	0.000751	CcSEcCtD
Cefadroxil—Hypersensitivity—Doxorubicin—ovarian cancer	0.000748	0.000748	CcSEcCtD
Cefadroxil—Asthenia—Doxorubicin—ovarian cancer	0.000729	0.000729	CcSEcCtD
Cefadroxil—Dizziness—Epirubicin—ovarian cancer	0.000726	0.000726	CcSEcCtD
Cefadroxil—Pruritus—Doxorubicin—ovarian cancer	0.000718	0.000718	CcSEcCtD
Cefadroxil—Vomiting—Epirubicin—ovarian cancer	0.000698	0.000698	CcSEcCtD
Cefadroxil—Diarrhoea—Doxorubicin—ovarian cancer	0.000695	0.000695	CcSEcCtD
Cefadroxil—Rash—Epirubicin—ovarian cancer	0.000692	0.000692	CcSEcCtD
Cefadroxil—Dermatitis—Epirubicin—ovarian cancer	0.000691	0.000691	CcSEcCtD
Cefadroxil—Headache—Epirubicin—ovarian cancer	0.000688	0.000688	CcSEcCtD
Cefadroxil—Dizziness—Doxorubicin—ovarian cancer	0.000671	0.000671	CcSEcCtD
Cefadroxil—Nausea—Epirubicin—ovarian cancer	0.000652	0.000652	CcSEcCtD
Cefadroxil—Vomiting—Doxorubicin—ovarian cancer	0.000646	0.000646	CcSEcCtD
Cefadroxil—Rash—Doxorubicin—ovarian cancer	0.00064	0.00064	CcSEcCtD
Cefadroxil—Dermatitis—Doxorubicin—ovarian cancer	0.00064	0.00064	CcSEcCtD
Cefadroxil—Headache—Doxorubicin—ovarian cancer	0.000636	0.000636	CcSEcCtD
Cefadroxil—Nausea—Doxorubicin—ovarian cancer	0.000603	0.000603	CcSEcCtD
